Water(Aqua), Glycerin, 1,2-Hexanediol, Polyglyceryl-10 Laurate, Hydrogenated Lecithin, Glutathione, Butylene Glycol, Chondrus Crispus Powder, Agar, Tromethamine, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Gellan Gum, Glycereth-26, Glyceryl Acrylate/Acrylic Acid Copolymer, Methylpropanediol, Vinyl Dimethicone, Dimethiconol, Niacinamide, Betaine, Sodium Polyacrylate, C18-21 Alkane, Polyglyceryl-10 Oleate, Isononyl Isononanoate, Isohexadecane, Ammonium Acryloyldimethyltaurate/VP Copolymer, Phenyl Trimethicone, Fragrance, Limonene, Citral, Ethylhexylglycerin, Xanthan Gum, Adenosine, Glucose, Caprylic/Capric Triglyceride, Ceramide NP, Palmitoyl Tripeptide-5, Sorbitan Laurate, Hydroxyethylcellulose, Acetyl Dipeptide-1 Cetyl Ester, Acetyl Hexapeptide-1, Thioctic Acid, Soluble Collagen

Our combination therapy of (-)-Vestitol and Salviolone, identified via network medicine, targets multiple AD-related pathways, including Neuroactive ligand-receptor interaction and Calcium signaling pathway, potentially offering a more comprehensive, disease-modifying approach
Aggregated peptides are essentially non-functional
These interactions are currently being examined to better understand how BPC-157 behaves under controlled laboratory conditions
It inhibits tyrosinase for skin brightening and is used as antioxidant and general wellness support